Canntab Therapeutics Limited announces private placement16,666,666 Common Shares at a issue price of CAD 0.006 per Common Share for gross proceeds of CAD 99,999.996 on April 15, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
15/04 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 142K | |
+43.96% | 6.34B | |
-15.56% | 4.51B | |
-6.52% | 3.29B | |
+5.47% | 3.2B | |
-0.76% | 2.59B | |
+56.34% | 2.09B | |
-4.11% | 1.76B | |
+2.93% | 1.7B | |
-8.02% | 1.62B |
- Stock Market
- Equities
- PILL Stock
- News Canntab Therapeutics Limited
- Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding